34.80
price up icon5.07%   1.68
after-market 시간 외 거래: 34.98 0.18 +0.52%
loading

Mineralys Therapeutics Inc (MLYS) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
5.17%
46.75
44.45 60.11 45.17 35.36
Operating Income/Loss
5.17%
-46.75
-44.45 -60.11 -45.17 -35.36
Nonoperating Income/Loss
55.28%
3.472
2.236 3.764 4.154 3.854
Income/Loss From Continuing Operations Before Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Income/Loss From Continuing Operations After Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Net Income/Loss
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Diluted Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Basic Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Diluted Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):